Montag & Associates’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24K Sell
7
-4
-36% -$679 ﹤0.01% 884
2025
Q4
$1.74K Sell
11
-3
-21% -$458 ﹤0.01% 876
2025
Q3
$2.08K Buy
14
+5
+56% +$788 ﹤0.01% 913
2025
Q2
$1.46K Hold
9
﹤0.01% 885
2025
Q1
$1.42K Buy
9
+3
+50% +$492 ﹤0.01% 925
2024
Q4
$936 Hold
6
﹤0.01% 957
2024
Q3
$1.01K Sell
6
-2
-25% -$341 ﹤0.01% 979
2024
Q2
$1.2K Hold
8
﹤0.01% 914
2024
Q1
$1.2K Buy
+8
New +$1.19K ﹤0.01% 908

Other funds holding BCPC

Montag & Associates's BCPC Position: Q1 2026 in Review

Montag & Associates reduced its Balchem Corp (BCPC) stake by 36% in Q1 2026, selling an estimated $679 and leaving 7 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #884.

Montag & Associates first reported a position in BCPC in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.08K in Q3 2025. 422 funds tracked by Wall St. Rank hold BCPC as of Q1 2026.

  • Montag & Associates held 7 shares of Balchem Corp worth $1.24K as of Q1 2026.
  • Montag & Associates sold 4 Balchem Corp shares in Q1 2026, an estimated $679.
  • Balchem Corp made up ﹤0.01% of Montag & Associates's portfolio in Q1 2026, its #884 holding.
  • Montag & Associates first reported a position in Balchem Corp in Q1 2024 and has held it in 9 quarters since.
  • Montag & Associates's Balchem Corp position peaked at $2.08K in Q3 2025.
  • 422 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.